Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (07/07/2016)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Small Cell Lung Cancer

Added a new Risk Factors subsection.

Revised text to state that prophylactic cranial radiation prevents central nervous system recurrence and can improve survival in patients with good performance status who have had a complete response or a very good partial response to chemoradiation in limited-stage disease or chemotherapy in extensive-stage disease.

This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Recurrent SCLC Treatment

Next section >
About This PDQ Summary